BAYER ADVIA CENTAUR HER-2/NEU ASSAY— 510(k) K024017
Substantially EquivalentBayer Corp.
FDA 510(k) clearance K024017 for BAYER ADVIA CENTAUR HER-2/NEU ASSAY, Substantially Equivalent on 2003-01-30. Applicant: Bayer Corp.. Device class: 2.
Clearance details
- Applicant
- Bayer Corp.
- Product code
- Code NCW
- Device class
- Class 2
- Regulation
- 21 CFR 866.6010
- Advisory panel
- Immunology
- Date received
- Decision date
- Decision
- Substantially Equivalent
- Clearance type
- Traditional
- Location
- Tarrytown, NY, US
Recent devices under product code NCW
view allMore clearances from Bayer Corp.
view all- K024062 — ASCENSIA BREEZE BLOOD GLUCOSE METER
- K023944 — BAYER DIAGNOSTICS CLINITEST PREGNANCY TEST
- K024234 — ASCENSIA GLUCOFACTS; ASCENSIA GLUCOFACTS PROFESSIONAL
- K022288 — COMPLEXED PROSTATE SPECIFIC ANTIGEN (CPSA) ASSAY FOR THE BAYER ADVIA INTEGRATED MODULE SYSTEM
- K023584 — ASCENSIA DEX 2 DIABETES CARE SYSTEM
Recalls naming K024017
K-number listed on FDA's recall recordMatched by K-number from FDA's Recall Enterprise System record (openFDA device/recallk_numbers) — these recalls explicitly list K024017.
Data sourced from openFDA. This site is unofficial and independent of the FDA.